Shewanella algae Peritonitis in Patients on Peritoneal Dialysis

被引:8
作者
Shanmuganathan, Malini [1 ]
Goh, Bak Leong [1 ]
Lim, Christopher [2 ]
NorFadhlina, Zakaria [2 ]
Fairol, Ibrahim [1 ]
机构
[1] Hosp Serdang, Dept Nephrol, Selangor, Malaysia
[2] Univ Putra Malaysia, Nephrol Unit, Serdang, Malaysia
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2016年 / 36卷 / 05期
关键词
Peritonitis; shewanella; PUTREFACIENS; BACTEREMIA; CARBAPENEM;
D O I
10.3747/pdi.2015.00287
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with peritonitis present with abdominal pain, diarrhea, fever, and turbid peritoneal dialysis (PD) fluid. Shewanella algae peritonitis has not yet been reported in PD patients in the literature. We present the first 2 cases of Shewanella algae peritonitis in PD patients. Mupirocin cream is applied on the exit site as prophylactic antibiotic therapy.
引用
收藏
页码:574 / U243
页数:2
相关论文
共 13 条
[1]   CAPD, swimming in Shewanella [J].
Bhandari, S ;
Pan, TLT ;
Horvath, J ;
Tiller, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (09) :1484-1485
[2]  
Chang CF, 2005, PERITON DIALYSIS INT, V25, P496
[3]   PERITONITIS CAUSED BY PSEUDOMONAS-PUTREFACIENS IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
DAN, M ;
GUTMAN, R ;
BIRO, A .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :359-360
[4]  
Derby H.A., 1931, IOWA EXP STA RES B, V145, P389
[5]   Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing Ambler class D β-lactamase from Shewanella algae [J].
Héritier, C ;
Poirel, L ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1670-1675
[6]   Shewanella algae and Shewanella putrefaciens:: clinical and microbiological characteristics [J].
Holt, HM ;
Gahrn-Hansen, B ;
Bruun, B .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (05) :347-352
[7]   Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens [J].
Khashe, S ;
Janda, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) :783-787
[8]   Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia [J].
Kim, DM ;
Kang, CI ;
Lee, CS ;
Kim, HB ;
Kim, EC ;
Kim, NJ ;
Oh, MD ;
Choe, KW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :1172-1174
[9]   ISOLATION AND CHARACTERIZATION OF SHEWANELLA-ALGA FROM HUMAN CLINICAL SPECIMENS AND EMENDATION OF THE DESCRIPTION OF S-ALGA SIMIDU ET-AL, 1990, 335 [J].
NOZUE, H ;
HAYASHI, T ;
HASHIMOTO, Y ;
EZAKI, T ;
HAMASAKI, K ;
OHWADA, K ;
TERAWAKI, Y .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1992, 42 (04) :628-634
[10]  
SHEWAN J. M., 1960, JOUR APPL BACT, V23, P379, DOI 10.1111/j.1365-2672.1960.tb00211.x